A federal judge in Texas has suspended the FDA's approval of the abortion pill, mifepristone, on April 7th, 2023. This decision could have far-reaching implications for women's access to abortion in the United States.
Mifepristone is a medication used to terminate an unwanted pregnancy and has been approved by the FDA since 2000. It is now the most common method of ending a pregnancy in the US, accounting for more than half of all abortions in the country. The decision to suspend its approval was made by U.S. District Judge Lee Yeakel in Austin and will likely be appealed to the U.S. Court of Appeals for the 5th Circuit, and potentially even make its way to the Supreme Court.
The ruling comes after a lawsuit was filed by anti-abortion groups challenging the FDA’s decision to allow mifepristone to be dispensed without a doctor’s prescription or physical visit to a clinic or hospital. The lawsuit argued that this practice put women at risk and violated federal drug safety laws. The judge agreed with these arguments and issued an injunction suspending mifepristone’s approval until further notice.
This ruling could have major implications for women seeking abortions in Texas and other states if it stands up on appeal. This could boost the population in the U.S. in which has been in decline for many years. Over the years, many efforts have been poured into depopulation tactics to reduce births not only in the United States, but across the globe.